Angiogenesis markers in sunitinib-treated clear-cell renal carcinoma patients.

被引：0
|
作者：
Kontovinis, Loukas
Papazisis, Konstantinos
Touplikioti, Panagiota
Mouratidou, Despoina
Boutis, Lazaros
Kortsaris, Alexandros
机构：
[1] Theagen Canc Hosp, Thessaloniki, Greece
[2] Interbalkan Med Ctr, Thessaloniki, Greece
[3] Democritus Univ Thrace, Alexandroupolis, Greece
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
235
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib
    Zimmermann, Kaja
    Schmittel, Alexander
    Steiner, Ursula
    Asemissen, Anne Marie
    Knoedler, Maren
    Thiel, Eckhard
    Miller, Kurt
    Keilholz, Ulrich
    ONCOLOGY, 2009, 76 (05) : 350 - 354
  • [12] Association between diabetes mellitus and the survival of sunitinib-treated patients with metastatic renal cell carcinoma.
    Suyama, Takahito
    Fujimoto, Ayumi
    Kanesaka, Manato
    Hou, Kyokushin
    Araki, Kazuhiro
    Masuda, Hiroshi
    Kojima, Satoko
    Sazuka, Tomokazu
    Nakamura, Kazuyoshi
    Nihei, Naoki
    Ichikawa, Tomohiko
    Naya, Yukio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [13] Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?
    P. Ivanyi
    J. Koenig
    A. Trummer
    J. F. Busch
    C. Seidel
    C. W. Reuter
    A. Ganser
    V. Grünwald
    World Journal of Urology, 2016, 34 : 909 - 915
  • [14] Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma
    Izzedine, H.
    Derosa, L.
    Le Teuff, G.
    Albiges, L.
    Escudier, B.
    ANNALS OF ONCOLOGY, 2015, 26 (06) : 1128 - 1133
  • [15] Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?
    Ivanyi, P.
    Koenig, J.
    Trummer, A.
    Busch, J. F.
    Seidel, C.
    Reuter, C. W.
    Ganser, A.
    Gruenwald, V.
    WORLD JOURNAL OF UROLOGY, 2016, 34 (07) : 909 - 915
  • [16] Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?
    Sabatier, R.
    Eymard, J. C.
    Walz, J.
    Deville, J. L.
    Narbonne, H.
    Boher, J. M.
    Salem, N.
    Marcy, M.
    Brunelle, S.
    Viens, P.
    Bladou, F.
    Gravis, G.
    ANNALS OF ONCOLOGY, 2012, 23 (03) : 714 - 721
  • [17] Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature
    Minardi, Daniele
    Quaresima, Luigi
    Santoni, Matteo
    Bianconi, Maristella
    Scartozzi, Mario
    Cascinu, Stefano
    Muzzonigro, Giovanni
    CURRENT UROLOGY REPORTS, 2015, 16 (02)
  • [18] Recent Aspects of Sunitinib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma: a Systematic Review of the Literature
    Daniele Minardi
    Luigi Quaresima
    Matteo Santoni
    Maristella Bianconi
    Mario Scartozzi
    Stefano Cascinu
    Giovanni Muzzonigro
    Current Urology Reports, 2015, 16
  • [19] Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib
    Beuselinck, Benoit
    Jean-Baptiste, Johnny
    Schoffski, Patrick
    Couchy, Gabrielle
    Meiller, Clement
    Rolland, Frederic
    Allory, Yves
    Joniau, Steven
    Verkarre, Virginie
    Elaidi, Reza
    Lerut, Evelyne
    Roskams, Tania
    Patard, Jean-Jacques
    Oudard, Stephane
    Mejean, Arnaud
    Lambrechts, Diether
    Zucman-Rossi, Jessica
    BJU INTERNATIONAL, 2016, 118 (06) : 890 - 901
  • [20] Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitors
    Haaker, Lorenz
    De Meue, Elisabeth
    Wildiers, Hans
    Verbiest, Annelies
    Dumez, Herlinde
    Lerut, Evelyne
    Pans, Steven
    Albersen, Maarten
    Beuselinck, Benoit
    ACTA CLINICA BELGICA, 2019, 74 (06) : 414 - 423
12345